Omniome

Very low-cost genomic and proteomic sequencing in silicon

First Investment: 2014

EXIT - Acquisition (Pacific Biosciences: PACB)

Omniome developed a proprietary DNA sequencing platform that delivered more accurate short reads than competing systems. Pacific Biosciences acquired the company in 2021.

News & Insights

Thoughts

Big Data Strikes Back: The Rise of Image, Sensor, and Genome Data Powering Deep Vertical Startups

Explore Companies

Samsara Eco

Sparing the climate through infinite recycling of plastic waste

Nium

Making green ammonia for fertilizer and energy transport

Visolis

Using synthetic biology to manufacture carbon-negative materials

Nobell Foods

Plant-grown dairy cheese